Interactions of organic anion transporters and organic cation transporters with mycotoxins.

Mycotoxins are secondary metabolites of moulds that which exert adverse effects in humans and animals. It is known that direct cellular toxicity is often associated with increased cellular accumulation of toxic compounds, and membrane transport may be the first fundamental stage in the development of the cytotoxicity. To elucidate the entry pathway for mycotoxins into cells, we have investigated the interactions of human and rat organic anion transporters (hOATs/rOats) and human organic cation transporters (hOCTs) with mycotoxins using cells stably expressing hOATs/rOats/hOCTs. The mycotoxins tested were aflatoxin B1, alpha-zearalenol, citrinin, citrioveridine, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, penicillic acid, rubratoxin B, and zearalenone. These mycotoxins inhibited organic anion uptake mediated by hOAT1-4, and organic cation uptake mediated by hOCT1-2. By comparing the IC(50) values of mycotoxins for hOATs, it was found that hOAT1 and hOAT3 exhibited higher affinity interactions with mycotoxins than hOAT2 and hOAT4. There was no interspecies difference between humans and rats for the interactions of OATs with mycotoxins except that of OAT3 with rubratoxin B. Finally, we observed that hOAT1-4 and hOCT1-2 mediated the uptake of aflatoxin B1. In conclusion, hOATs and hOCTs interacted with various mycotoxins. Considering the localization of hOATs/rOats and hOCTs, it was suggested that these transporters were the possible entrance pathway for mycotoxins in kidney and liver, leading to the induction of adverse effects in humans and rats.

[1]  R. Phillips,et al.  Effects of citrinin on renal function and structure. , 1980, Toxicology.

[2]  S. Masuda,et al.  Cellular and molecular aspects of drug transport in the kidney. , 2000, Kidney international.

[3]  F. Lang,et al.  Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.

[4]  G. You The role of organic ion transporters in drug disposition: an update. , 2004, Current drug metabolism.

[5]  H. Endou,et al.  Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. , 2001, European journal of pharmacology.

[6]  A. Enomoto,et al.  Role of human organic anion transporter 4 in the transport of ochratoxin A. , 2002, Biochimica et biophysica acta.

[7]  D. Becroft,et al.  Aflatoxins and Reye's disease. , 1972, British medical journal.

[8]  I. Tamai,et al.  Organic anion transporters. , 1999, Pharmaceutical biotechnology.

[9]  Heinz Bönisch,et al.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.

[10]  T. Massey,et al.  ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. , 1997, Molecular pharmacology.

[11]  J. Kim,et al.  Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta* , 2000, The Journal of Biological Chemistry.

[12]  A novel effect of bifemelane, a nootropic drug, on intracellular Ca2+ levels in rat cerebral astrocytes. , 2006, Journal of pharmacological sciences.

[13]  H. Endou,et al.  Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[14]  P. Meier,et al.  Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  G. Burckhardt,et al.  Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles , 2007, Pharmaceutical Research.

[16]  G. Burckhardt Polyspecific Organic Cation Transport: Insights into the Substrate Binding Site , 2005, Molecular Pharmacology.

[17]  Y. Kanai,et al.  Cloning and Characterization of a Novel Multispecific Organic Anion Transporter * , 1997 .

[18]  K. Giacomini,et al.  Cloning and functional expression of a human liver organic cation transporter. , 1997, Molecular pharmacology.

[19]  P. Mathur,et al.  Study of an epidemic of jaundice, presumably due to toxic hepatitis, in Northwest India. , 1977, Gastroenterology.

[20]  Y. Kanai,et al.  Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. , 1999, The American journal of physiology.

[21]  Y. Kanai,et al.  Organic anion transporter family: current knowledge. , 2006, Journal of pharmacological sciences.

[22]  K. Jung,et al.  Characterization of ochratoxin A transport by human organic anion transporters. , 2001, Life sciences.

[23]  R. Hartley,et al.  Toxicity and Fluorescence Properties of the Aflatoxins , 1963, Nature.

[24]  Y. Kanai,et al.  Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. , 2001, Molecular pharmacology.

[25]  D. Meijer,et al.  Drug uptake systems in liver and kidney. , 2003, Current drug metabolism.

[26]  A. Enomoto,et al.  Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[27]  A. Enomoto,et al.  Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. , 2002, The Journal of pharmacology and experimental therapeutics.

[28]  楠原 洋之 薬物トランスポーター, 膜輸送の基礎から薬物動態・生理的役割まで(7)腎臓, 脳(血液脳関門, 血液脳脊髄液関門)における有機アニオンの排泄メカニズムとしての Organic Anion Transporter (OAT) の役割(2) , 2003 .

[29]  M. Obinata,et al.  Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene , 1996, Archives of Toxicology.

[30]  Maristela L Onozato,et al.  Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. , 2003, Journal of pharmacological sciences.

[31]  H. Kusuhara,et al.  Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain* , 1999, The Journal of Biological Chemistry.

[32]  Y. Kanai,et al.  Transport of ochratoxin A by renal multispecific organic anion transporter 1. , 1998, The Journal of pharmacology and experimental therapeutics.

[33]  P. Howard,et al.  Rat Kidney Pathology Induced by Chronic Exposure to Fumonisin B1 Includes Rare Variants of Renal Tubule Tumor , 2001, Toxicologic pathology.

[34]  W. H. Butler,et al.  Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. , 1969, Cancer research.

[35]  J. Pitt Toxigenic fungi and mycotoxins. , 2000, British medical bulletin.

[36]  D. Keppler,et al.  ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. , 2000, Kidney international.